<DOC>
	<DOC>NCT03062072</DOC>
	<brief_summary>To assess chemotherapy related hyperglycemia in non-diabetic patients, the investigators will assess the incidence of hyperglycemia and analyze co-medications and risk factors.</brief_summary>
	<brief_title>Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Antineoplastic Agents</mesh_term>
	<criteria>Patients with cancers (colorectal, breast) who treated with curative intents and ones with malignant lymphoma who are expected to achieve complete remission with chemotherapy (mainly, CHOP regimen) Patients without history of diabetes mellitus Normal glucose tolerance, as defined in the protocol Patients with diabetes mellitus or hyperglycemia, as defined in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>normoglycemia</keyword>
	<keyword>cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>Hyperglycemia Drug Induced</keyword>
</DOC>